Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sias is a leading Swiss developer and supplier of modular laboratory automation solutions, specializing in robotic liquid handling systems and functional modules for the life sciences and diagnostics sectors. Founded in 2000, the company is best known for its Xantus modular pipetting robot and Ixion robot-friendly microplate centrifuge, which facilitate automated workflows in research and clinical laboratories. Sias operates primarily as an original equipment manufacturer (OEM), providing specialized components and complete systems that are integrated into the products of major diagnostic and pharmaceutical partners. In 2015, Sias was acquired by the Tecan Group, where it was integrated into Tecan's Partnering Business to leverage global sales and support infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIAS.